This is the authors' abstract. We don't add key points for this paper.
The extensive use of antiviral substances (SASs) during and after the COVID-19 pandemic has increased their release into wastewater systems, raising concerns regarding their persistence and potential ecotoxicological effects. The primary objective of this study was to isolate bacterial strains from activated sludge (AS) that possess the ability to biodegrade SASs. From the AS sample, three bacterial species, Comamonas testosteroni (I2), Bacillus amyloliquefaciens (I3) and Bacillus mycoides (I4), were successfully isolated and identified. These strains were subsequently applied in biodegradation experiments targeting seven SASs: daclatasvir (DCV), darunavir (DRV), favipiravir (FAV), lopinavir (LOP), remdesivir (REM), ritonavir (RIT), and umifenovir (UMI). During the experiments, residual SAS concentrations, microbial growth parameters, physicochemical indicators and ecotoxicity were monitored. All three strains demonstrated substantial biodegradation potential, achieving reductions exceeding 90% for most tested compounds, with particularly low toxicity observed in experiments conducted with AS and Bacillus amyloliquefaciens. These findings highlight the relevance of AS-derived bacteria as promising candidates for enhancing SAS removal in wastewater treatment processes.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Lastovčić et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: